Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in IndiaPublished on 8 January 2014 @ 3:57 pm
Intellectual Property Watch
An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally.
CPhI’s 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies.
The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets.
The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries.
Click here to view the region-wise agenda.
Free download for IP-Watch Readers! Click here to view presentations from 2013!
Categories: Biodiversity/Genetic Resources/Biotech, Developing Country Policy, Education/ R&D/ Innovation, English, IP Law, IP-Watch Briefs, Patents/Designs/Trade Secrets, Public Health, Technical Cooperation/ Technology Transfer